[1]
J. Houpe, E. Fan, F. Siddiqui, E. Seger, and A. Rajpara, “The utility of frequent laboratory monitoring for patients on tumor necrosis factor-alpha inhibitors in dermatology”, kjm, vol. 15, no. 2, pp. 212–214, Jun. 2022.